Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 55NIH 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 107Neoplasms 70Colorectal Neoplasms 51Uterine Cervical Neoplasms 41Prostatic Neoplasms 32Stomach Neoplasms 31Motor Activity 26Carcinoma, Hepatocellular 24Lung Neoplasms 22Rectal Neoplasms 21Colonic Neoplasms 19Head and Neck Neoplasms 18Pancreatic Neoplasms 17Brain Neoplasms 15Pain 14Polycystic Ovary Syndrome 13Recurrence 12Pain, Postoperative 11Lymphoma 11Esophageal Neoplasms 11Anxiety Disorders 11Ovarian Neoplasms 10Glioma 10Endometrial Neoplasms 10Thyroid Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Pilonidal Sinus 9Carcinoma, Non-Small-Cell Lung 9Papillomavirus Infections 8Hematologic Neoplasms 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all
NCT03062436 2019-07-23

To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

Command Hospital, India

Phase NA Unknown
27 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡